B47.0
Eumycetoma
Clinical Classification Guidelines
Inclusion Terms
- Madura foot, mycotic
- Maduromycosis
Medical Intelligence & Overview
Eumycetoma, classified under ICD-10 code B47.0, is a chronic fungal infection primarily affecting the skin and subcutaneous tissues. Often referred to as Madura foot, this condition is characterized by swelling, abscesses, and the formation of sinus tracts that can discharge pus and grains containing fungal hyphae. It is a rare mycotic disease that can cause significant tissue destruction if not diagnosed and treated early. Eumycetoma falls under the broader category of mycetoma, which also includes bacterial (actinomycetoma) origins. Understanding the causes, symptoms, diagnosis, and treatment options helps in managing the disease effectively.
Causes & Symptoms
Clinical Causes: Infection by specific types of fungi (eumycetes), most commonly Madurella species Inoculation of fungal spores through traumatic skin injuries, often involving plant material or soil contaminated with fungi Repeated exposure to environments rich in fungal spores, particularly in rural or agricultural settings Poor hygiene and delayed wound care that facilitate fungal entry Compromised immune system, which increases susceptibility to fungal infections
Key Symptoms: Progressive swelling of the affected area, usually the foot or lower leg Formation of painless or minimally painful nodules that gradually enlarge Development of sinus tracts that exude cloudy or serous fluid containing characteristic grains or granules Discoloration of the skin over the affected region Ulceration of the skin surface in advanced stages Chronic, indolent course with potential for tissue destruction and deformity Lymphedema or swelling beyond the initial site in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of eumycetoma generally involves a combination of clinical examination and laboratory tests. Key diagnostic steps include: - **Medical history review** focusing on exposure to fungi and occupational risks. - **Physical examination** to identify characteristic swelling, sinuses, and grains. - **Imaging studies**, such as X-rays or MRI, to assess the extent of tissue and bone involvement. - **Microscopic examination** of grains from discharge to identify fungal hyphae. - **Culture tests** to isolate and identify the specific fungal species. - **Histopathological analysis** of tissue biopsies to confirm fungal presence and rule out other conditions. Accurate diagnosis is crucial to differentiate eumycetoma from bacterial mycetoma and other skin conditions that may mimic its presentation.
Treatment Protocols: Management of eumycetoma involves a combination of medical and surgical interventions: - **Antifungal therapy**: Long-term use of antifungal medications such as itraconazole, ketoconazole, or others, depending on the fungal species and sensitivity. - **Surgical intervention**: Excision of the affected tissue may be necessary to remove fungal masses, especially in advanced cases. - **Debridement**: Removal of necrotic tissue to promote healing and reduce fungal load. - **Supportive care**: Rest and elevation of the affected limb to decrease swelling. - **Monitoring and follow-up**: Regular evaluations to assess response to therapy and detect potential recurrence. Early diagnosis and treatment are essential to prevent extensive tissue damage and deformity. Due to the chronic nature of the disease, treatment often extends over several months, emphasizing the need for close medical supervision.
Clinical Advice & FAQs
Billing Guidance
Is B47.0 a billable ICD-10 code?
Yes, B47.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B47.0?
Clinical documentation must specify the nature of Eumycetoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
